Prof. Brandacher, you recently returned to the Medical University of Innsbruck from Johns Hopkins University in the USA. Could you tell us something about your research projects and, in particular, about the long-term preservation of organs?
Prof. Gerald Brandacher: One of our main research goals is to develop a highly specialized cooling technique that makes it possible to preserve organs for longer periods of time. It has always been possible to freeze or refrigerate organs, but research has encountered the problem of ice formation during thawing.
This ice formation led to cell damage and tissue damage, making the storage of organs at ultra-low temperatures almost impossible. However, significant progress has been made in recent years to prevent or at least minimize this ice formation.
Nature has served as inspiration for this development. Various animal species, such as fish, frogs and other survivors in extremely cold environments, have the ability to generate protective proteins. These proteins prevent the formation of ice and protect the organs from damage. Researchers have now been able to chemically synthesize these proteins and use them therapeutically.
Can you tell us more about the cold preservation technology and how it is used?
Brandacher: The cold preservation technology we are researching involves supercooling and vitrification, where organs are preserved without the formation of ice. This allows organs to be stored for days, weeks or even months. These methods are already being used in reproductive medicine to preserve embryos and egg cells.
Temperature plays a decisive role here. By lowering the temperature to ultra-low temperatures of around -150 degrees Celsius, the tissue enters a so-called glass stage in which it can be stored indefinitely.
However, we are currently focusing on an approach that is probably more practical, with a temperature range between -5 and -10 degrees. Here, organs can be transported completely without ice formation through the use of cryoprotective peptoids. We believe that with this technology it will be possible to gain viability of between three and ten days. This would allow organs to be exchanged worldwide.